bioAffinity Technologies Posts $5.89 Q3 GAAP Loss Per Share

John Kim

1 min read

Add as a preferred source on Google

bioAffinity Technologies Posts $5.89 Q3 GAAP Loss Per Share

Third-quarter revenue fell 21.4% year over year to $1.1 million.

By John Kim

Published Nov 8, 2026, 5:01 PM EST

Loose coins sit in one corner of a nearly empty glass box / TokenPost.ai

bioAffinity Technologies posted a $5.89 GAAP loss per share in the third quarter, as revenue fell 21.4% year over year to $1.1 million for the three months ended Sept. 30.

Cash and cash equivalents totaled about $2.6 million on Sept. 30, compared with $6.4 million on Dec. 31, 2025.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.